Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2 | Zendy

Guillaume ButlerLaporte | Zendy; Alexander Lawandi | Zendy; Ian Schiller | Zendy; Mandy Yao | Zendy; Nandini Dendukuri | Zendy; Emily G. McDonald | Zendy; Todd C. Lee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2

Author(s) -

Guillaume ButlerLaporte,

Alexander Lawandi,

Ian Schiller,

Mandy Yao,

Nandini Dendukuri,

Emily G. McDonald,

Todd C. Lee

Publication year - 2021

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2020.8876

Subject(s) - medicine , meta analysis , nucleic acid amplification tests , medline , virology , chlamydia trachomatis , political science , law

Nasopharyngeal swab nucleic acid amplification testing (NAAT) is the noninvasive criterion standard for diagnosis of coronavirus disease 2019 (COVID-19). However, it requires trained personnel, limiting its availability. Saliva NAAT represents an attractive alternative, but its diagnostic performance is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research